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ABSTRACT 
 
Organophosphorus containing nerve agents (OP’s) are a threat to the general 
public due to their facile synthesis and high toxicity.  The current methods for treatment 
require immediate intervention after exposure to the OP’s.  We are proposing the use of 
prophylactic bioscavenger butyrylcholinesterase (BuChE) as a preventative measure 
against these weapons.  In order to better understand the biodistribution of these 
bioscavengers, we want to append a tag that will allow for in vivo measurement of the 
distribution. The tag we propose to use is a tetrathiatriarylmethyl radical. These 
compounds are stable in biological systems and can be observed by electron 
paramagnetic resonance (EPR) spectroscopy.  Previously, these trityl radicals have been 
successfully prepared and used as sensors for molecular oxygen in biological systems.  
Enclosed are reports of improved large-scale synthesis of three different types of 
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 Organophosphorus containing nerve agents (OP’s) are a threat to the general public 
due to their facile synthesis and high toxicity. Their lethality presents itself by 
interrupting or stimulating the nervous system. As early as the 1930’s, OP’s were used as 
common insecticides and were later developed into neurotoxins. As synthesis of these 
nerve agents developed, numerous derivatives of OP’s have been synthesized by the 
esterification of phosphoric acid.1 Some structures of common OP’s are shown in Figure 
1. 
 
Figure 1: Structures of organophosphates. 
 
Between 1961 and 1968, the United States synthesized approximately 4400 tons of VX 
for chemical warfare purposes. This amount had the potential to kill the entire population 
of the world. Today, organophosphorus compounds are a rising concern against the 
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have been used against civilian populations; and it is likely that they will be used again 
due to their ease of synthesis. “Approximately 3,000,000 people are exposed to 
organophosphates each year, with up to 300,000 fatalities. In the United States, there 
were more than 8,000 reported exposures to these agents in 2008, resulting in fewer than 
15 deaths”2,3,4 The ability to create chemical protection against these compounds is of 
great importance. 5,6 
 OP’s bind a serine residue (Ser-203) in the active site of AChE yielding a 
phosphorylated protein. Nucleophilic substitution by the hydroxyl group of Ser-203 
yields the inhibited AChE. This first binding step is reversible with pharmaceuticals such 
as Pralidoxime, however, after a short amount of time ranging from minutes to hours 
depending on the size of the organophosphates R groups, binding becomes irreversible 
resulting in an aged AChE active site. This binding inhibits AChE indefinitely leading to 
the accumulation of acetylcholine in the nerve synapses.8 This accumulation inevitably 
leads to the paralysis of neuromuscular function. Possible reversal of the phosphorylated 
protein involves the use of quinone methides (QM’s) such as o-quinone methide. QM’s 
are able to act as phosphoester alkylating agents. By alkylating the phosphate, there is 
potential for AChE to become reactivated, thus, eliminating any of the unfavorable 
effects caused by OP’s. Specific pharmaceuticals for nerve agents include:  Pralidoxime 
Chloride and Atropine shown in Figure 3.  
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Figure 2: Structures of common oxime pharmaceuticals. 
 
Pralidoxime chloride regenerates cholinesterase by reversing the phosphorylation of 
AChE previous to the aging process. Atropine has antagonistic affects at muscarinic 
receptors in the central nervous system.8   
 OP’s are competitively bound or degraded by bioscavengers which affords a 
minimal level of protection to the critical enzyme acetylcholinesterase (AChE): “a key 
protein in control of neurotransmission at cholinergic synapses”.7 The inhibition of this 
enzyme affects “neuromuscular transmission” and in turn can cause loss of vital muscle 
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Figure 3: AChE phosphorylation and aging by OP’s followed by dephosphorylation. 
 
It is possible to use a prophylactic bioscavenger like butyrylcholinesterase (BuChE) as a 
preventative measure against these weapons. The ability to create some sort of protection 
against OP’s is an advantage of bioscavengers: “protein-based enzymes of human origin 
capable of reacting with nerve agents and degrading them into harmless products.” 8 OP’s 
are competitively bound or degraded by these bioscavengers, which affords a minimum 
level of protection to the critical enzyme acetylcholinesterase. The ability of BuChE to 
































Figure 4: Various forms of BuChE and membrane interactions.9 
 
In Figure 4, a schematic representation of the different molecular forms of BuChE and its 
ability to bind to membranes is shown. BuChE can exist in three soluble forms 
designated G1 (symmetric monomeric), G2 (dimeric), and G4 (tetramer).9  These forms of 
BuChE are typically bound to membranes through protein anchors that are rich in proline 
(PRiMA).9 Other types of protein anchors include Collagen Q which has a triple helical 
form and allows for BuChE to assemble in the extracellular matrix. 
 Studies of BuChE’s distribution in the brain have been extensively studied by using 
a variety of biochemical methods such as enzyme isolation in order to quantify the 
enzyme’s concentrations. However, it is likely that the recorded concentrations were 
underestimated due to the reagents being used that inhibit BuChE.9 Since the ability to 
monitor the biodistribution of biological agents is currently not well understood and is of 
great importance, adjusting the way to monitor BuChE in vivo requires specific 
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instrumentation. Understanding the biodistribution of protein-based therapeutics using 
electron paramagnetic resonance imaging (EPRI) is of great importance when 
determining molecular oxygen concentrations in the human body. This method has been 
proven to be effective for determining free radicals in biological systems. By appending 
the bioscavenger with a stable radical via a linker (Figure 5), its biological distribution 
could be measured in vivo.   
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The goal is to develop a trityl radical library to use as biological sensors via EPR that will 
have multiple applications to study biodistribution. Applications include the testing of 
these EPR spin probes for conjugation to BuChE, treatment of enzymes inhibited by OP’s 
in order to gain information of the bioscavenger, and applying this technology to other 
macromolecules to better understand their distribution in vivo.    
 


































































































































































 Tetrathiatriarylmethyl radicals (Figure 6) are excellent probes in biological electron 
paramagnetic resonance spectroscopy. They demonstrate stability in biological tissue and 
have a half-life ranging from couple hours to 24 hours.10 The development of these 
possible image-enhancing triarylmethal radicals will allow for effective spin labeling and 
a greater understanding of biological distribution in-vivo. The sulfur derivatives are of 
particular interest since they demonstrate greater advantages than those of the oxygen 
radicals. These advantages include an enhanced stability, improved water solubility, and 











Figure 7: EPR spectra of trityl radical 1. 
 
In order for these compounds to be effective, it is important they are exemplified through 
a long half-life, do not induce an immune response, are water-soluble and demonstrate a 
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sharp signal in the EPRI. A sharp signal is necessary in order to obtain high sensitivity 
signals in vivo. Such a signal is achieved by eliminating any hyperfine couplings within 
the spectra. Signals acquired from such a spectrum is of importance because it aids in the 
understanding of the distribution of BuChE.12, 13  
 Currently many challenges exist when trying to determine a proteins 
biodistribution. A useful technique would be to tag a specific protein with a biomarker 
that would be able to be identified through non-invasive EPR spectroscopy. Advantages 
of non-invasive techniques such as EPRI compared to MRI for example is that “tagged 
proteins” can be determined at very low concentrations and this technique will allow for 
imaging of only the “tagged proteins”. Hopefully through the continued experimentation 
and observations of the distribution of bioscavengers in a lab setting, understanding how 
trityl radicals degrade will probe improved stability for these radical systems.  With this 
data in hand, we hope to perfect the synthesis of these biomarkers to the point of human 
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CHAPTER 2 
SYNTHESIS OF ARYL TRITYL RADICALS 
 
 The formations of the initial precursors to all of the aryl trityl radicals in this thesis 
begin with 1,2,4,5-tetrachlorobenzene. These procedures have been optimized for the 
synthesis of all of the materials including the initial nucleophilic aromatic substitution 
reaction and thio-acetal formation shown in Scheme 2.1.1, 2, 3, 4 
 
Scheme 2.1. Nucleophilic aromatic substitution and acetal formation 1.4. 
 
Compound 1.3 was formed by nucleophilic aromatic substitution on a suspension of 
sodium metal and 1.1 in DMF over a period of 4 h. The resulting solution was refluxed at 
160 ºC for 24 h. The product was precipitated and purified by washing with water to yield 
1.2 as a grey solid (86%). GC/MS and NMR analysis of this compound verified it to be 
analytically pure. Compound 1.2 was synthesized by an acid catalyzed ether cleavage 
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HBF4.Et2O was added. The resulting mixture was allowed to reflux at 130 ºC for 24 h. 
The product was isolated after neutralization with saturated sodium bicarbonate,  and 
triturated with a 1:1 mixture of acetone/methanol to yield 1.3 as an off white solid (81%). 
Both steps were optimized for time, concentration, and yield by monitoring with GC/MS. 
It should also be noted that the reaction scale could be performed on excess of 100 g with 
out any chromatography to afford 1.4. 1,2,4,5-tetra-tert-butylthiobenzene (1.2) was 
produced in greater yields than that from the literature (63%) due to optimized 
equivalents and conditions. When previous reports in the literature were attempted, 
GC/MS showed a mixture of both di- and tri-substituted butylthiobenzene after the 
allocated time. Our modified conditions provide tetra-substitution in excellent yield as 























































Figure 8: Gas chromatogram of compound 1.2 from literature procedure. 
Figure 9: Gas chromatogram mass spectra of modified preparation of 1.2. 
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The alternate synthesis optimized the equivalents, going from less than 5 to 6 equivalents  
of sodium and 1.1 and also increased the reaction time from 2 h to 24 h at reflux. 
Application of these alterations provided significant improvement of yield and purity. 
 With this starting material (1.4) in hand in large quantities we began our attempt to 
prepare the trityl radicals. A novel synthetic route was developed to produce the trityl 
alcohol (1.8) via formation of a ketone as shown in Scheme 2.2. 
 
 
Scheme 2.2: Nucleophilic addition to Aldehyde and preparation of aryl anion 1.5. 
 
Compound 1.5 was synthesized via generation of the anion prepared from 1.4 with 
subsequent addition of DMF to yield the aldehyde. A suspension of 1.4 in THF, TMEDA 
and n-BuLi at 0 ºC were added respectively and the reaction was allowed to stir for 3 h, 
after which DMF was added. After purification by column chromatography a yield of 
75% was achieved. Compound 1.6 was similarly synthesized by preparation of the 



































1. n-BuLi, TMEDA, 1.4







































(1.6). To a suspension of 1.4 in THF, TMEDA was added followed by the addition of n-
BuLi, dropwise at -78 ºC for 2 h. The resulting yellow oil was purified via column 
chromatography to give a yield of 65%. Compound 1.6 was then oxidized to 1.7 using 
Dess Martin Periodinane (DMP) and sodium bicarbonate. A slurry of 1.6, DMP, sodium 
bicarbonate, and DCM was cooled to 0 ºC and monitored for complete oxidation by TLC. 
The slurry was extracted with DCM, evaporated down in vacuo and purified by column 
chromatography in a 98% yield. By generating the bisthioacetal anion followed by the 
addition of compound 1.7, 1.8 was achieved in very low yields. We believe the yield to 
be low due to the bulkiness of the aryl monomers. Solvent concentration, temperature and 
time proved to be important. This alternate method to prepare 1.8 will allow for the 
propagation of unsymmetrical trityl alcohols that we will utilize in our future work.  
 We also optimized a method for synthesis of 1.8 by trimerization of 1.4 with 
methylchloroformate, TMEDA and n-BuLi to generate the trityl alcohol, 1.8 in a yield of 







Scheme 2.3: Trimerization of anion with methyl chloroformate to yield 1.8. 
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To a suspension of 1.4 and toluene, TMEDA was added, followed by the dropwise 
addition of n-BuLi at -5 ºC. The reaction was allowed to cool in an ice bath with calcium 
chloride for 30 min, then continued to stir for another 1.5 h. The reaction was allowed to 
stir for an additional 48 h and was purified using column chromatography to give 1.8, a 
yellow powder in a 49% yield. The ability to trimerize 1.4 allows for optimized use of 
starting materials and a greater potential to make symmetric derivatives of the trityl 
alcohol by added various R groups to act as linkages for proteins. The ability to develop 
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Experimental 
 General. Solvents were distilled from the appropriate drying agents before use. 
Unless stated otherwise, all reactions were carried out under a positive pressure of 
nitrogen and were monitored by TLC on silica gel 60 F254 (0.25 mm, E. Merck). Spots 
were detected under UV light or by PMA in ethanol. Solvents were evaporated under 
reduced pressure and below 40 ºC (bath). Organic solutions of crude products were dried 
over anhydrous MgSO4. Chromatography was performed on silica gel 60 (40-60 µM). 
The ration between silica gel and crude product ranged from 100 to 50:1 (w/w). Melting 
points are uncorrected. 1H NMR spectra were recorded at 250 and 400 MHz, and 
chemical shifts are referenced to TMS (0.0, CDCl3). 13C NMR spectra were recorded at 
100 MHz, and 13C shifts are referenced to CDCl3 (77.0, CDCl3). Electrospray mass 
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1,2,4,5-Tetra-tert-butylthiobenzene (1.3). To a 1.0 L RBF equipped with a magnetic 
stirbar was added DMF (500 mL) and 1.1 (126 g, 158 mL, 1.392 mol). The mixture was 
stirred and small chunks of sodium were cut under hexanes and slowly added to the 
reaction over a 4 h period during which the color changed from yellow to dark red. After 
the sodium was completely dissolved, 1.2 (49.80 g, 0.2306 mol) was added and the 
mixture was refluxed in an oil bath at 160 ºC for 24 h. The mixture was cooled to 
rt (23 ºC) and was then poured over ice (500 g). The precipitate was isolated by vacuum 
filtration, washed with water (3 x 100 mL) to result in a grey solid (86.26 g, 0.200 mol, 
86%). 1H NMR (250 MHz, CDCl3): δ 1.36 (s, 36H), 7.74 (s, 2H); 13C NMR (100 MHz, 
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2,2,6,6-Tetramethylbenzol[1,2-d;4,5-d]bis[1,3]dithiole (1.4). To a 1.0 L RBF equipped 
with a magnetic stirbar was added acetone (24 mL, 327 mmol), toluene (240 mL, 2.25 
mol), and 1.3 (25.86 g, 60 mmol) at room temperature (23 ºC). HBF4.Et2O (12.36 mL) 
was added dropwise via syringe. The reaction was stirred for 4 h and then refluxed in an 
oil bath at 130 ºC for 24 h. The resulting black solution was allowed to cool to rt and 
extracted using diethyl ether (3 x 20 mL) and saturated sodium bicarbonate (2 x 120 mL). 
The combined organic phase was dried and evaporated under reduced pressure to a 
brown solid. The resulting solid was triturated with acetone/methanol (w:w) to yield a 
pale yellow solid (8.75 g, 30.60 mmol, 51%). 1H NMR (250 MHz, CDCl3): δ 1.33 (s, 
36H), 7.73 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 31.5, 49.2, 134.2, 140.0; 
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2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis([1,3]dithiole)-4-carbaldehyde (1.5). To a 
flame dried 100 mL RBF containing 1.4 (1.80 g, 6.29 mmol) and magnetic stirbar under 
N2, was charged with anhydrous THF (31.45 mL). The solution was cooled to 0 ºC and 
freshly distilled TMEDA (1.423 mL, 9.44 mmol) was added via syringe. n-BuLi (2.5 M 
in hexanes, 2.706 mL, 6.604 mmol) was added dropwise over a period of 5 min at 0 ºC. 
The ice bath was removed and the reaction stirred for 3 h. Anhydrous DMF (0.734 mL, 
9.44 mmol) was added in one portion upon which the reaction went from dark red to a 
burnt orange in color. The reaction was allowed to stir for 24 h and water (4.0 mL) was 
added to the resulting yellow solution. The mixture was portioned with DCM and washed 
with 1M H2SO4 (2 x 20 mL) and saturated sodium bicarbonate. The combined organic 
phase was dried and the resulting orange liquid was evaporated under reduced pressure. 
The crude compound was purified by column chromatography (silica, 100:1 
hexanes:EtOAc) to give 1.5 as a yellow-orange solid (1.481 g, 4.71 mmol, 75%). 1H 
NMR (400 MHz, CDCl3): δ 1.88 (s, 12H), 7.18 (s, 1H), 10.1 (s, 1H); 3C NMR (100 MHz, 
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Bis(2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis([1,3]dithiole)-4-yl)methanol (1.6). A 
flame dried 50 mL RBF equipped with a magnetic stirbar and 1.4 (0.950 g, 3.32 mmol, 
1.05 eq) was charged with anhydrous THF (16.6 mL) under an N2 atmosphere at room 
temperature (23 ºC). Freshly distilled TMEDA (0.506 mL, 3.36 mmol, 1.06 eq) was 
added and the reaction was cooled to -78 ºC. n-BuLi (1.82M in hexanes, 1.85 mL, 1.06 
eq) was added dropwise over 30 min while at -78 ºC. The reaction was kept at -78 ºC for 
1 h. Compound 1.5 (1.0 g, 3.17 mmol, 1.0 eq) was dissolved in THF (10 mL) and added 
via cannula and the reaction was allowed to stir for 2 h at -78 ºC. The crude reaction 
mixture was portioned between water and DCM. The organic phase was washed with 
H2SO4 (1 M, 3 x 10 mL) and saturated NaHCO3). The combined organic phase was dried, 
filtered, and concentrated to give crude brown-orange oil. The crude was purified by 
column chromatography (silica, 33% DCM in hexanes) which gave compound 1.6 as a 
yellow solid (1.16 g, 1.933 mmol, 61%). 1H NMR (400 MHz, CDCl3): δ 1.82 (s, 24H), 
2.64 (1, 2H), 5.67 (d, 1H), 7.06 (s, 1H) ; 13C NMR (100 MHz, CDCl3) δ 30.6, 31.3, 


















	   22	  




Bis(2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis([1,3]dithiole)-4-yl)methanone (1.7). To 
a 100 mL RBF equipped with magnetic stirbar was added 1.6 (1.074 g, 1.79 mmol, 1.0 
eq), DMP (1.90 g, 4.48 mmol, 2.5 eq) and anhydrous sodium bicarbonate (0.15 g, 1.93 
mmol, 1.0 eq). The mixture of solids was suspended in DCM (9.0 mL) while cooling to 0 
ºC. After 10 min, the ice bath was removed and the reaction was monitored by TLC (75% 
EtOAc in hexanes).  After completion, a bright orange color was observed. NaOH (10 
mL). The mixture was then extracted with DCM (3 x 10 mL). The organic phase was 
dried, filtered and evaporated under reduced pressure to obtain a crude oil. The crude oil 
was purified by column chromatography (silica, 25% DCM in hexanes) to yield 
compound 1.7 as a bright orange solid (1.05 g, 1.75 mmol, 98%). 1H NMR (400 MHz, 
CDCl3): δ 1.81 (s, 24H), 7.15 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 31.0, 65.2, 119.0, 
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Tris(2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis([1,3]dithiole)-4-yl)methanol (1.8). To a 
flame dried 100 mL RBF equipped with magnetic stirbar under N2 was added 1.4 (0.40 g, 
1.40 mmol, 2.1 eq) and toluene (10 mL). Distilled TMEDA (0.21 mL, 1.40 mmol, 2.10 
eq) was added and the reaction was cooled to -78 ºC. n-BuLi (1.67 M in hexanes, 0.80 
mL, 2.0 eq) was added dropwise over 5 min and the reaction was allowed to stir for 2 h. 
Compound 1.7 (0.402 g, 0.67 mmol, 1.0 eq) was dissolved in toluene (10 mL) and added 
via cannula, after which the ice bath was removed and the reaction was allowed to stir for 
24 h. The reaction was extracted with DCM (3 x 10 mL), and washed with brine (20 mL). 
The organic phase was dried, filtered and evaporated under reduced pressure to yield a 
crude oil. The crude oil was purified with column chromatography (silica, 1% EtOAc in 
hexanes) as a yellow solid. 1H NMR (400 MHz, CDCl3): 1H NMR (400 MHz, CDCl3) δ 
1.68 (s, 9H), 1.72 (s, 9H), 1.80 (s, 9H), 1.82 (s, 9H), 6.23 (s, 1H), 7.17 (s, 3H); HRMS= 
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Experimental: Trimerization of 1.4 to yield 1.8 
 
Tris(2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis([1,3]dithiole)-4-yl)methanol (1.8). To a 
flame dried 25 mL round bottomed flask equipped with magnetic stirbar, 1.4 (1 eq.) was 
added.  The flask was purged with N2 and charged with anhydrous toluene.  Freshly 
distilled TMEDA (1 eq.) was then added to the reaction.  The flask was cooled to -10 °C.  
To the mixture was added n-BuLi (1.1 eq) was added dropwise.  Upon the addition of n-
BuLi, the reaction changed from a pale transparent yellow to dark transparent orange.  
The reaction was kept at -10 °C for 30 min, at which point the ice bath was removed and 
the reaction was allowed to stir at room temperature (23 ºC) for 1.5 h.  The reaction was 
cooled again to -10 °C and distilled methylchloroformate (0.33 eq) was added dropwise.  
The reaction was allowed to stir for an additional 18 h. The reaction was extracted with 
DCM (3 x 10 mL), and washed with brine (20 mL). The organic phase was dried, filtered 
and evaporated under reduced pressure to yield a crude oil. The crude oil was purified 
with column chromatography (silica, 1% EtOAc in hexanes) as a yellow solid. 1H NMR 
(400 MHz, CDCl3): δ 1.5  (s, 36H), 5.32 (s, 1H), 7.19 (s, 3H); HRMS=885.0575; 
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CHAPTER 3 
STUDIES TOWARDS THE PREPARATION OF ARYL TRITYL RADICALS 
WITH LINKERS 
  
 Developing a new synthetic route that involves creating trityl radicals that can be 
used to link to proteins is the ultimate goal of this research. We hope that some of our 
previously described methods can be applied to synthesize compounds in good yields and 
high purity. These different linkages will allow for orthogonal protein tagging and 
different signals in EPRI. Formation of the TMS-alkyne begins with compound 1.5 and 




Scheme 3.1: Corey Fuchs reaction to prepare alkyne aryl precursor 1.10. 
 
Compound 1.9 was synthesized via a suspension of PPh3 and CBr4 in DCM followed by 
dropwise addition of compound 1.5 in DCM at -5 ºC. The reaction was allowed to stir for 
1 h and monitored by TLC until completion. The product was isolated by column 
chromatography, in a yield of 86%. With 1.9 in hand, we converted it to the 
corresponding TMS-alkyne by adding it to a suspension of compound 1.9 in THF at – 78 





















1. n-BuLi, THF, -78 ºC
2. TMS-Cl
1.10
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TMS-Cl was added. The reaction was allowed to stir for 15 h and then purified by  
column chromatography to yield compound 1.10 in a 64% yield. 
 Compound 1.10 was then successfully converted to the tertiary alcohol (1.11) by 
addition to ketone 1.7 in low yield as previously observed.  
 
 
             
Scheme 3.2: TMS-alkyne addition to produce trityl alcohol with TMS linker 1.11. 
 
 
To a suspension of compound 1.10 in toluene was added n-BuLi, TMEDA at 0 ºC. The 
reaction was allowed to stir for 2 h. Compound 1.7 was dissolved in toluene and added 
via cannula and monitored using TLC. The reaction was allowed to stir for 16 h and 
extracted in brine and DCM. The organic phase was purified using column 
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 We also optimized a method for trimerizing 1.10 using TMEDA, n-BuLi, and 
methylchloroformate to generate the tri- substituted TMS trityl alcohol, 1.12.   
 
 
         
Scheme 3.3: Trimerization of anion with methyl chloroformate to yield 1.12. 
 
To a suspension of 1.10 and toluene, TMEDA was added, followed by the dropwise 
addition of n-BuLi at -5 ºC. The reaction was allowed to cool in an ice bath with calcium 
chloride for 30 min, then continued to stir for another 1.5 h. Methylchloroformate was 
added dropwise and allowed to come to rt over the next 18 h. The reaction was extracted 
with brine and DCM and purified using column chromatography to give 1.12, a dark red 
oil in a 11% yield. The ability to trimerize 1.10 allows for optimized use of this new 
starting material and provides a greater potential to make symmetrical derivatives of the 
trityl alcohol by added various R groups other than TMS to act as linkages for proteins. It 
has been observed that the optimal synthesis of these trityl alcohols has been produce via 
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alcohol via Corey Fuchs followed by addition to compound 1.7.  
Experimental 
 General. Solvents were distilled from the appropriate drying agents before use. 
Unless stated otherwise, all reactions were carried out under a positive pressure of 
nitrogen and were monitored by TLC on silica gel 60 F254 (0.25 mm, E. Merck). Spots 
were detected under UV light or by PMA in ethanol. Solvents were evaporated under 
reduced pressure and below 40 ºC (bath). Organic solutions of crude products were dried 
over anhydrous MgSO4. Chromatography was performed on silica gel 60 (40-60 µM). 
The ration between silica gel and crude product ranged from 100 to 50:1 (w/w). Melting 
points are uncorrected. 1H NMR spectra were recorded at 250 and 400 MHz, and 
chemical shifts are referenced to TMS (0.0, CDCl3). 13C NMR spectra were recorded at 
100 MHz, and 13C shifts are referenced to CDCl3 (77.0, CDCl3). Electrospray mass 
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4-(2,2-dibromovinyl)-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis([1,3]dithiole) (1.9). A 
flame dried 100 ml RBF equipped with magnetic stirbar was added CBr4 (2.10 g, 6.36 
mmol, 2.0 eq). The flask was purged with N2, charged with anhydrous DCM (4.9 mL), 
and cooled to -5 ºC. PPh3 (3.34 g, 12.72 mmol, 4.0 eq) was added via powder funnel and 
the reaction turned dark yellow/orange. The contents were allowed to stir for 30 min. 
Compound 1.5 (1.0 g, 3.18 mmol, 1 eq) was dissolved in DCM (40 mL) and added to the 
contents via cannula. TLC was used to monitor depletion of the starting material. DCM 
was added to the RBF and the crude organic phase was purified with column 
chromatography (silica, 0.33% EtOAc in hexanes) to yield 1.9 as a yellow solid (1.2732 
g, 2,7215 mmol, 86%). 1H NMR (400 MHz, CDCl3): δ 1.91 (s, 12H), 7.03 (s, 1H), 7.30 
(s, 1H); 13C NMR (100 mHz, CDCl3): δ 31.3, 65.5, 96.6, 116.4, 117.7, 126.1, 135.2, 
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yl)ethynyl)silane (1.10). A flame dried 100 mL RBF containing a magnetic stirbar, 1.9 
(1.160 g, 2.479 mmol, 1.0 eq) was purged with N2 and charged with anhydrous THF (25 
mL). The reaction was cooled to -78 ºC and n-BuLi (2.5 M in hexanes, 2.28 mL, 2.3 eq) 
was added dropwise over 5 min. The reaction was allowed to stir for 3 h. TMS-Cl (0.808 
g, 0.943 mL, 7.437 mmol, 3.0 eq) was added to the contents which turned a dark green 
color. The reaction was allowed to stir for an additional 16 h. Water (10 mL) was added 
and the reaction was extracted with DCM (3 x 10 mL), and washed with brine (20 mL). 
The organic phase was dried, filtered and evaporated under reduced pressure to yield a 
crude oil. The crude oil was purified with column chromatography (silica, 10% DCM in 
hexanes) to yield 1.10 as a yellow solid (0.6053 g, 1.593 mmol, 64 %). 1H NMR (400 
MHz, CDCl3): δ 0.28 (s, 9H), 1.91 (d, 12H), 6.92 (s, 1H); 13C NMR (100 mHz, CDCl3): δ 
-0.05, 13.7, 22.0, 31.8, 64.7, 100.9, 104.6, 111.9, 115.9, 134.7, 139.5; HRMS= 382.0354; 
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Experimental: Mono-substituted TMS trityl alcohol (1.11) 
 
(2,2,6,6-tetramethyl-8-((trimethylsilyl)ethynyl)benzo[1,2-d:4,5-d']bis([1,3]dithiole)-4-
yl)bis(2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis([1,3]dithiole)-4-yl)methanol (1.11). A 
flame dried 100 mL RBF containing a magnetic stirbar and 1.10 (1.5381 g, 4.026 mmol, 
3.0 eq) was purged with N2 and charged with anhydrous toluene (20 mL). Freshly 
distilled TMEDA (0.607 mL, 4.026 mmol, 3.0 eq) was added and the contents were 
cooled to -78 ºC. n-BuLi (2.7 M in hexanes, 1.50 mL, 2.98 eq) was added dropwise and 
the reaction was allowed to stir for 2 h. Compound 1.7 (0.8025 g, 1.342 mmol, 1.0 eq) 
was dissolved in toluene (24 mL) and added via cannula upon which the reaction turned a 
dark olive green. The organic phase was extracted with DCM (3 x 10 mL), and washed 
with brine (20 mL). The organic phase was dried, filtered and evaporated under reduced 
pressure to yield a crude oil. The crude oil was purified with column chromatography 
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Experimental: Trimerization of 1.10 to yield 1.11 
 
Tris(2,2,6,6-tetramethyl-8-((trimethylsilyl)ethynyl)benzo[1,2-d:4,5-
d']bis([1,3]dithiole)-4-yl)methanol (1.12). A flame dried 25 mL RBF containing 
magnetic stirbar and compound 1.10 (500 mg, 1.308 mmol, 1.0 eq) was purged with N2 
and charged with anhydrous toluene. Freshly distilled TMEDA (0.1975 mL, 1.3089 
mmol, 1.0 eq) was added and the reaction was cooled to -5 ºC. n-BuLi (2.0 M in hexanes, 
0.7198 mL, 1.439 mmol, 1.1 eq) was added dropwise and the content turned a dark deep 
red color. The ice bath was removed after 30 min and the reaction was allowed to stir for 
1.5 h. Methylchloroformate (0.033 mL, 0.4319 mmol, 0.33 eq) was added and the 
reaction was allowed to stir for 16 h. The organic phase was extracted with DCM (3 x 10 
mL), and washed with NH4Cl (20 mL) and brine (20 mL). The organic phase was dried, 
filtered and evaporated under reduced pressure to yield a crude oil. The crude oil was 
purified with column chromatography (silica, 1% EtOAc in hexanes) to yield 1.12 as a 
dark red oil (11 %). 1H NMR (400 MHz, CDCl3): δ 0.28 (s, 27H), 1.23 (s, 1H), 1.80 (s, 
36H); 13C NMR (100 mHz, CDCl3): δ -0.05, 13.7, 22.0, 31.8, 64.7, 100.9, 104.6, 111.9, 
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CONCLUSION 
 In the future, we hope to continue to build the trityl radical library by attaching 
various R groups onto compound 1.4 and either trimerizing them to form symmetrical 
trityl radicals, or through addition to compound 1.7 to develop potential non-symmetric 
trityl radicals. The future will be focused on developing other trityl radicals. We will also 
begin to look at the linkage of these types of compounds to proteins in the appropriate 
linker strategy. We hope to be able to remove the TMS group to a terminal alkyne and 
then use the resulting alkyne in a click reaction as shown below. 
 
Figure 10: Click Reaction 
 
 With access to different trityl radicals, the ability for orthogonal protein tagging is 
made possible. The goal is to develop a trityl radical library to use as biological sensors 
via EPR that will have multiple applications. Applications include the testing of these 
EPR spin probes for conjugation to BuChE, treatment of enzymes inhibited by OP’s in 
order to gain information of the bioscavenger, and apply this technology to other proteins 
to better understand their distribution in vivo. The development of these possible image-
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understanding of molecular oxygen concentrations in-vivo.   
 
